These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia. Knapp HH; Schrott H; Ma P; Knopp R; Chin B; Gaziano JM; Donovan JM; Burke SK; Davidson MH Am J Med; 2001 Apr; 110(5):352-60. PubMed ID: 11286949 [TBL] [Abstract][Full Text] [Related]
3. Low-dose combination therapy with colesevelam hydrochloride and lovastatin effectively decreases low-density lipoprotein cholesterol in patients with primary hypercholesterolemia. Davidson MH; Toth P; Weiss S; McKenney J; Hunninghake D; Isaacsohn J; Donovan JM; Burke SK Clin Cardiol; 2001 Jun; 24(6):467-74. PubMed ID: 11403509 [TBL] [Abstract][Full Text] [Related]
4. Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. Ballantyne CM; Houri J; Notarbartolo A; Melani L; Lipka LJ; Suresh R; Sun S; LeBeaut AP; Sager PT; Veltri EP; Circulation; 2003 May; 107(19):2409-15. PubMed ID: 12719279 [TBL] [Abstract][Full Text] [Related]
5. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial. Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB; Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446 [TBL] [Abstract][Full Text] [Related]
6. Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia. Davidson M; Ma P; Stein EA; Gotto AM; Raza A; Chitra R; Hutchinson H Am J Cardiol; 2002 Feb; 89(3):268-75. PubMed ID: 11809427 [TBL] [Abstract][Full Text] [Related]
7. A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia. Davidson MH; Donovan JM; Misir S; Jones MR Am J Cardiovasc Drugs; 2010; 10(5):305-14. PubMed ID: 20860413 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia. Lee SH; Chung N; Kwan J; Kim DI; Kim WH; Kim CJ; Kim HS; Park SH; Seo HS; Shin DG; Shin YW; Shim WJ; Ahn TH; Ho Yun K; Yoon MH; Cha KS; Choi SW; Han SW; Hyon MS Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy. McKenney JM; Koren MJ; Kereiakes DJ; Hanotin C; Ferrand AC; Stein EA J Am Coll Cardiol; 2012 Jun; 59(25):2344-53. PubMed ID: 22463922 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study. Knopp RH; Tsunehara C; Retzlaff BM; Fish B; Nguyen H; Anderson S; Nguyen T Metabolism; 2006 Dec; 55(12):1697-703. PubMed ID: 17142146 [TBL] [Abstract][Full Text] [Related]
11. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia. Bays HE; Davidson M; Jones MR; Abby SL Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial. Insull W; Toth P; Mullican W; Hunninghake D; Burke S; Donovan JM; Davidson MH Mayo Clin Proc; 2001 Oct; 76(10):971-82. PubMed ID: 11605698 [TBL] [Abstract][Full Text] [Related]
13. Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects. Davidson MH; Dillon MA; Gordon B; Jones P; Samuels J; Weiss S; Isaacsohn J; Toth P; Burke SK Arch Intern Med; 1999 Sep; 159(16):1893-900. PubMed ID: 10493319 [TBL] [Abstract][Full Text] [Related]
14. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E; Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231 [TBL] [Abstract][Full Text] [Related]
15. Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome. Hunninghake DB; Ballantyne CM; Maccubbin DL; Shah AK; Gumbiner B; Mitchel YB Clin Ther; 2003 Jun; 25(6):1670-86. PubMed ID: 12860491 [TBL] [Abstract][Full Text] [Related]
16. Comparison of atorvastatin alone versus simvastatin +/- cholestyramine in the management of severe primary hypercholesterolaemia (the six cities study). Simons LA Aust N Z J Med; 1998 Jun; 28(3):327-33. PubMed ID: 9673745 [TBL] [Abstract][Full Text] [Related]
17. Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Blair SN; Capuzzi DM; Gottlieb SO; Nguyen T; Morgan JM; Cater NB Am J Cardiol; 2000 Jul; 86(1):46-52. PubMed ID: 10867091 [TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy and tolerability of simvastatin and atorvastatin in the treatment of hypercholesterolemia. Recto CS; Acosta S; Dobs A Clin Cardiol; 2000 Sep; 23(9):682-8. PubMed ID: 11016019 [TBL] [Abstract][Full Text] [Related]
19. Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intolerance. Rivers SM; Kane MP; Busch RS; Bakst G; Hamilton RA Endocr Pract; 2007; 13(1):11-6. PubMed ID: 17360295 [TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled, 8-week study to evaluate the efficacy and safety of once daily atorvastatin (10 mg) in patients with elevated LDL-cholesterol. Wang KY; Ting CT Jpn Heart J; 2001 Nov; 42(6):725-38. PubMed ID: 11933922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]